Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief ...

Spanish plasma-based medicines producer Grifols has announced the execution of an agreement for a private placement of 1.3 ...

Canada-headquartered Bausch + Lomb Corporation, a leading global eye health company, on Thursday confirmed reports that it is ...

Poland-based drug developer Ryvu Therapeutics, a clinical-stage drug discovery biotech, yesterday provided an update on ...

Based on its review of post-market clinical trial data, the US Food and Drug Administration (FDA) identified cases of serious ...

UK-based Tenpoint Therapeutics and Seattle’s Visus Therapeutics have announced the completion of their merger to create an ...

BenevolentAI restructures to focus on modular AI technology and extend its financial runway into 2027. The company may delist ...

Danish allergy immunotherapy specialist ALK Abello announced that its European regulatory filing for Acarizax (house dust ...

US pharma giant Pfizer and Alliance Foundation Trials (AFT) have announced results from the Phase III PATINA trial.

Eli Lilly announces a $15 billion share buyback, three times its previous largest program, highlighting strong financial ...

USA-based Elevation Oncology, an innovative oncology company focused on the discovery and development of selective cancer ...